Skip to main content
Top February Tweet:
ACR Task Force published guidelines on RMD drug use w/ COVID vaccines.

My views:
1. I agree, no

Dr. John Cush RheumNow

5 years 7 months ago
Top February Tweet: ACR Task Force published guidelines on RMD drug use w/ COVID vaccines. My views: 1. I agree, no change most DMARD, biologics 2. I disagree; I would NOT hold Orencia, I would NOT hold JAKi 3. I disagree: I would not hold MTX https://t.co/uSPfvJB8EC https://t.co/unOY1jvzTJ
Compared with no statin use; statin use in RA pts is assoc w/ 28% lower mortality risk. Population study of 19,614 RA pt

Dr. John Cush RheumNow

5 years 7 months ago
Compared with no statin use; statin use in RA pts is assoc w/ 28% lower mortality risk. Population study of 19,614 RA pts w/ incident statin use, compared 1,883 statin users vs 1,883 nonusers. All-cause mortality was lower (HR 0.72;0.56-0.91) w/ statins https://t.co/onMlWoVdPL
QD Clinic - Self-Medicating Myself
The pendulum and jury are wavering with regard to the benefits of interleukin-6 receptor antagonists in COVID-19; the current NEJM reports the results of a study favoring such biologic therapy in in critically ill COVID-19 patients.
RheumNow Live is a powerful, interactive meeting delivered by researchers, educators, & clinicians.

The speaker li

Dr. John Cush RheumNow

5 years 7 months ago
RheumNow Live is a powerful, interactive meeting delivered by researchers, educators, & clinicians. The speaker list includes: Roy Fleischmann, Alan Matsumoto, Clay Cockerell, Eric Ruderman, Alexis Ogdie, Philip Robinson, Jeff Sparks, and more. https://t.co/vJlU0Z3Q3x https://t.co/fRbQbGRwoR
Pooled analysis of 16 observational RA registries (27 583 patients) shows that seropositivity was associated with better

Dr. John Cush RheumNow

5 years 7 months ago
Pooled analysis of 16 observational RA registries (27 583 patients) shows that seropositivity was associated with better remission, LDAS and withdrawal rates for RTX and ABA, but not TNF inhibitors. https://t.co/aNphJpB7JB
Systemic Sclerosis is 5 times more prevalent in women than men. Analysis of epidemiology studies shows SSc prevalence a

Dr. John Cush RheumNow

5 years 7 months ago
Systemic Sclerosis is 5 times more prevalent in women than men. Analysis of epidemiology studies shows SSc prevalence as 17.6 per 100000 and pooled incidence of SSc was 1.4 per 100000 PYs. https://t.co/RyVIBUWyen
Its sill not SAFE! Avoid congregate settings! CDC report shows among 81 who participated in indoor high-intensity exerc

Dr. John Cush RheumNow

5 years 7 months ago
Its sill not SAFE! Avoid congregate settings! CDC report shows among 81 who participated in indoor high-intensity exercise classes - 68% developed COVID-19. 40% with COVID-19 attended class on day Sxs began. Most (76%) wore masks infrequently https://t.co/KLZauJUupN
In Israel (as of Feb 2021) 84% of those ≥70 years and 10% for <50 years have received 2 doses of the COVID Vaccine;

Dr. John Cush RheumNow

5 years 7 months ago
In Israel (as of Feb 2021) 84% of those ≥70 years and 10% for <50 years have received 2 doses of the COVID Vaccine; as such the need for mechanical ventilation in the elderly has declined 67% with the implementation of COVID vaccines. https://t.co/9Qnv72QYUS
Listen to last weeks QD Clinics Podcasts (134-137 Feb 26) - RA or Not
QD137 - RA or Not
QD136 - Periorbital Mass
QD13

Dr. John Cush RheumNow

5 years 7 months ago
Listen to last weeks QD Clinics Podcasts (134-137 Feb 26) - RA or Not QD137 - RA or Not QD136 - Periorbital Mass QD135 - Periorbital Edema QD134 - PFAPA Syndrome https://t.co/pMXm6vFuBl
My Experience as a COVID19 Vaccine Trial Participant

https://t.co/ILfXLUL8IZ

Dr. John Cush RheumNow

5 years 7 months ago
My Experience as a COVID19 Vaccine Trial Participant https://t.co/ILfXLUL8IZ
×